Use of an APL peptide for the treatment of inflammatory bowel disease and type 1 diabetes

Details for Australian Patent Application No. 2009335405 (hide)

Owner Centro De Ingenieria Genetica Y Biotecnologia

Inventors Barbera Betancourt, Ariana; Dominguez Horta, Maria del Carmen; Lorenzo Perez, Norailys; Padron Palomares, Gabriel Ramon; Falcon Cama, Viviana; Menendez Valdes, Ivon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009335405

PCT Pub. Number WO2010/075824

Priority 2008-0254 29.12.08 CU

Filing date 29 December 2009

Wipo publication date 8 July 2010

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

25 August 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Use of an APL peptide for the treatment of inflammatory bowel disease and type 1 diabetes 2010

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/075824 Priority application(s): WO2010/075824

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335460-Pharmaceutical formulations comprising voriconazole and processes for preparation thereof

2009335398-Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof